Perspectives for therapy of treatment-resistant depression

Review considers development of appropriate regulatory framework for novel rapidly acting antidepressants (ADs), efficacy of non-pharmacological somatic therapies, animal models to understand AD non-response and potential for rapid AD action from targets beyond glutamate receptor

British Journal of Clinical Pharmacology